Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Combs

Showing results (81-90 of 594) with videos related to

Pageof 60
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 7, 2017
[Critical consideration of the European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas]Sophia Scharl, Christoph Straube, Bernhard Meyer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 20, 2005
Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT)Stephanie E Combs, Sybille Gutwein, Christoph Thilmann, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 18, 2011
p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737Katrin E Tagscherer, Anne Fassl, Tabea Sinkovic, et al.
Acta Oncologica (Stockholm, Sweden)|June 13, 2012
Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent gliomaStephanie E Combs, Lutz Edler, Renate Rausch, et al.
Radiation Oncology (London, England)|January 1, 2013
State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniquesStephanie E Combs, Ute Ganswindt, Robert L Foote, et al.
Cells|October 2, 2019
Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922Annett Kühnel, Daniela Schilling, Stephanie E Combs, et al.
Radiation Oncology (London, England)|April 25, 2014
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?Sebastian Adeberg, Tilman Bostel, Laila König, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2009
Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomasStephanie E Combs, Thomas Welzel, Daniela Schulz-Ertner, et al.
Cancers|December 23, 2023
SBRT of Spinal Metastases Using a Simultaneous Integrated Boost Concept in Oligometastatic Cancer Patients Is Safe and EffectiveMaria Waltenberger, Christian Strick, Marco M E Vogel, et al.
Radiation Oncology (London, England)|March 23, 2012
Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study conceptsStefan Rieken, Daniel Habermehl, Thomas Haberer, et al.
Pageof 60

Showing results (81-90 of 594) with videos related to

Sort By:
Pageof 60
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 7, 2017
[Critical consideration of the European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas]Sophia Scharl, Christoph Straube, Bernhard Meyer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 20, 2005
Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT)Stephanie E Combs, Sybille Gutwein, Christoph Thilmann, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 18, 2011
p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737Katrin E Tagscherer, Anne Fassl, Tabea Sinkovic, et al.
Acta Oncologica (Stockholm, Sweden)|June 13, 2012
Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent gliomaStephanie E Combs, Lutz Edler, Renate Rausch, et al.
Radiation Oncology (London, England)|January 1, 2013
State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniquesStephanie E Combs, Ute Ganswindt, Robert L Foote, et al.
Cells|October 2, 2019
Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922Annett Kühnel, Daniela Schilling, Stephanie E Combs, et al.
Radiation Oncology (London, England)|April 25, 2014
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?Sebastian Adeberg, Tilman Bostel, Laila König, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2009
Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomasStephanie E Combs, Thomas Welzel, Daniela Schulz-Ertner, et al.
Cancers|December 23, 2023
SBRT of Spinal Metastases Using a Simultaneous Integrated Boost Concept in Oligometastatic Cancer Patients Is Safe and EffectiveMaria Waltenberger, Christian Strick, Marco M E Vogel, et al.
Radiation Oncology (London, England)|March 23, 2012
Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study conceptsStefan Rieken, Daniel Habermehl, Thomas Haberer, et al.
Pageof 60